Podcasts about schizophrenia research

You're invited to ask an expert about interesting topics related to employment. This free event is not a presentation, but rather an interactive question & answer webinar. And YOU provide the questions! Susan R. McGurk, PhD, is a Professor in the Departments of Occupational Therapy (primary appointment) and Psychological and Brain Sciences, and a researcher at the Center of Psychiatric Rehabilitation at Boston University. She is a clinical psychologist and neuropsychologist whose research has focuses on the role of cognitive functioning in employment, academic pursuits, and independent living in persons with serious mental illnesses (SMI), and methods and mechanisms of cognitive remediation aimed at improving cognitive abilities and community functioning in this population. Drs McGurk and Mueser developed the Thinking Skills for Work TSW program, a comprehensive cognitive remediation intervention designed to enhance cognitive functioning and improve competitive work outcomes in persons receiving supported employment or other vocational rehabilitation services. Her work has been supported by the Biobehavioral Research Foundation (formerly NARSAD), the National Institute of Mental Health (NIMH), the National Institute for Disability and Independent Living Research and Rehabilitation (NIDILRR), New York State Office of Mental Health, and the Coalition of Voluntary Mental Health Agencies-New York Work Exchange. She has received the Gerard Hogarty Award for Excellence in Schizophrenia Research and was recognized by the National Rehabilitation Association with the Rehabilitation Practitioner of Distinction Award.

Renzo Huber is a staff scientist at NIH. We talk about his work on layer-fMRI: what it  is, how Renzo got into it, how to do it, when it makes sense to do it, what the future holds, and much more.Support the show: https://geni.us/bjks-patreonTimestamps0:00:00: How Renzo got into high-resolution fMRI0:11:28: The difference between 3T and 7T fMRI0:22:46: Is a bigger fMRI scanner always better?0:33:35: Layer-fMRI0:56:28: For what types of research is layer-fMRI most useful?1:02:35: How to do layer-fMRI and make it reproducible1:19:21: The future of layer-fMRI1:27:02: A book or paper more people should read1:30:37: Something Renzo wishes he'd learnt sooner1:33:11: Advice for PhD students/postdocsPodcast linksWebsite: https://geni.us/bjks-podTwitter: https://geni.us/bjks-pod-twtRenzo's linksWebsite: https://geni.us/huber-webGoogle Scholar: https://geni.us/huber-scholarTwitter: https://geni.us/huber-twtBen's linksWebsite: https://geni.us/bjks-webGoogle Scholar: https://geni.us/bjks-scholarTwitter: https://geni.us/bjks-twtReferences and links mentionedEpisode with Peter Bandettini: https://geni.us/bjks-bandettiniEpisode with Emily Finn: https://geni.us/bjks-finnRenzo's blog about layer fMRI: https://layerfmri.com/YouTube channel on layer fMRI: https://www.youtube.com/@layerfmri/Bastos, ... & Friston (2012). Canonical microcircuits for predictive coding. Neuron.Bollmann & Barth (2021). New acquisition techniques and their prospects for the achievable resolution of fMRI. Progress in Neurobiology.Boulant, ... & Le Bihan (2024). In vivo imaging of the human brain with the Iseult 11.7-T MRI scanner. Nature Methods.Finn, ... & Bandettini (2019). Layer-dependent activity in human prefrontal cortex during working memory. Nature Neuroscience.Feynman (1985). "Surely you're joking, Mr. Feynman!": adventures of a curious character.Haarsma, Kok & Browning (2022). The promise of layer-specific neuroimaging for testing predictive coding theories of psychosis. Schizophrenia Research.Huber, ... & Bandettini (2017). High-resolution CBV-fMRI allows mapping of laminar activity and connectivity of cortical input and output in human M1. Neuron.Huber, ... & Möller (2019). Non-BOLD contrast for laminar fMRI in humans: CBF, CBV, and CMRO2. Neuroimage.Huber, ... & Bandettini (2020). Sub-millimeter fMRI reveals multiple topographical digit representations that form action maps in human motor cortex. Neuroimage.Huber, ... & Kronbichler (2023). Evaluating the capabilities and challenges of layer-fMRI VASO at 3T. Aperture Neuro.Huber, ... & Horovitz (2023). Laminar VASO fMRI in focal hand dystonia patients. Dystonia.Persichetti, ... & Martin (2020). Layer-specific contributions to imagined and executed hand movements in human primary motor cortex. Current Biology.Polimeni, ... & Wald (2010). Laminar analysis of 7 T BOLD using an imposed spatial activation pattern in human V1. Neuroimage.

Join Dr Nick, Miss Diagnosis, Prudence Dear and Dr Sonia to chat to Dr Tina Thomas, a Senior Research Fellow for the Centre for Palliative Care on discussions around end-of-life care. Plus, Professor Ashley Bush from the University of Melbourne on new research exploring the link between Schizophrenia and Iron Metabolism.

In this episode, we address the troubling reality of suicide rates among individuals grappling with schizophrenia. Studies reveal a staggering statistic, up to 15% of those with schizophrenia tragically take their own lives. This alarming figure, particularly affecting young people in the early stages of their illness, underscores the urgency of our conversation.Join us as we delve into this topic with Dr. William Honer, Jack Bell Chair in Schizophrenia Research, and a professor at the University of British Columbia's Department of Psychiatry. Together, we'll explore the complex factors contributing to this, aiming to foster understanding, address stigma, and advocate for comprehensive support systems.Resources:Suicide Crisis HotlineSee omnystudio.com/listener for privacy information.

In this episode of the Smarter Not Harder Podcast, our guest Dr. Susan Rossell joins our host Jodi Duval to give one-cent solutions to life's $64,000 questions that include: How have the media and popular culture shaped our perceptions of what the ideal body should look like and how these influences can lead to serious psychological and social implications? How does body dysmorphic disorder (BDD) affect people emotionally and socially making it difficult for them to recognize and respond to the emotions of others? What are the current and upcoming treatment options available for body image disorders, including psychotherapy, antidepressants, oxytocin, and brain training?   Dr. Susan Rossell is a cognitive neuropsychologist and Professorial Research Fellow at Swinburne's Centre for Mental Health. She also holds adjunct positions at Monash Alfred Psychiatry Research Centre and at St Vincent's Health. Professor Rossell's research focuses on understanding the cognitive and neurobiological processes involved in psychosis and related disorders. She has published extensively and received both the International and European award for Young Investigator in Schizophrenia Research.   What we discuss: (0:02:00) - Body Image (0:04:30) - Toxic Body Positivity (0:07:10) - Body Dysmorphia Through a Biological and Psychological Perspective  (0:13:21) - Body Dysmorphia's Impact on Emotions (0:19:42) - Gender Differences in Body Image Disorders (0:22:10) - Body Image versus Vanity  (0:26:27) - The Rise of Dsitress in Body Image (0:29:55) - Fear of Aging (0:34:15) - The Impact of Social Media Filters  (0:40:57) - Body Image Treatment Options (0:48:06) - Body Image Survey and Getting Help (0:52:36) - Knowledge, Psilocybin, and Body Image   Find more from Smarter Not Harder: Website: https://troscriptions.com/blogs/podcast | https://homehope.org Instagram: @troscriptions | @homehopeorg   Find out more from Dr. Susan Rossell Twitter: @RossellSusan   Get 10% Off Your Purchase of the Metabolomics Module by using PODCAST10 at https://www.homehope.org   Get 10% Off your Troscriptions purchase by using POD10 at https://www.troscriptions.com   Get daily content from the hosts of Smarter Not Harder by following @troscriptions on Instagram.  

To participate in the FOCUS Online study, please visit the following link: https://forms.office.com/r/eXfRT1ZanZ. Matthew Roché, PhD, is the Director of Outcomes Research. Matt earned his PhD in clinical psychology at State University of New York at Binghamton and had pre- and post-doctoral appointments in the Division of Schizophrenia Research at the University of Medicine and Dentistry/Robert Wood Johnson Hospital and Rutgers University. After completing his training, Matt served in Research Specialist and faculty capacities at Rutgers where he worked collaboratively with pharmaceutical, private research, and start-up firms;  worked on scale development for clinical phenomenon in schizophrenia and schizophrenia-spectrum disorders; assisted in protocol development for projects evaluating the role of Huntington's disease, schizophrenia, and Parkinson's disease on retinal cell functioning; and, developed and led trainings on clinical rating scales and diagnostic interviewing. In addition, Matt taught in various graduate (masters and doctoral) programs at Rutgers. Matt is currently an Assistant Professor in the Department of Psychology at New Jersey City University. Matt joined CHDI in 2018.

The big media denial of the facts and fat from wheat.

https://psychiatry.dev/wp-content/uploads/speaker/post-12303.mp3?cb=1679214076.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Long-term effects of Roluperidone on negative symptoms of schizophrenia – Jonathan Rabinowitz et al. Schizophrenia Research. 2023. Roluperidone has antagonist properties forFull EntryLong-term effects of Roluperidone on negative symptoms of schizophrenia –

https://psychiatry.dev/wp-content/uploads/speaker/post-12299.mp3?cb=1679210211.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Trait schizotypy and the psychosis prodrome: Current standard assessment of extended psychosis spectrum phenotypes – Julia-Katharina Pfarr et al. Schizophrenia Research. 2023.Full EntryTrait schizotypy and the psychosis prodrome: Current standard assessment of extended psychosis spectrum phenotypes –

https://psychiatry.dev/wp-content/uploads/speaker/post-12295.mp3?cb=1679206451.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Seasonality of presentation and birth in catatonia – Tomas Mastellari et al. Schizophrenia Research. 2023. Catatonia is a neuropsychiatric syndrome associated withFull EntrySeasonality of presentation and birth in catatonia –

https://psychiatry.dev/wp-content/uploads/speaker/post-12291.mp3?cb=1679202775.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Linguistic correlates of suicidal ideation in youth at clinical high-risk for psychosis – Matthew F Dobbs et al. Schizophrenia Research. 2023. SuicidalFull EntryLinguistic correlates of suicidal ideation in youth at clinical high-risk for psychosis –

https://psychiatry.dev/wp-content/uploads/speaker/post-12287.mp3?cb=1679151416.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: A psychosocial pathway to paranoia: The interplay between social connectedness and self-esteem – Manel Monsonet et al. Schizophrenia Research. 2023. The quantityFull EntryA psychosocial pathway to paranoia: The interplay between social connectedness and self-esteem –

https://psychiatry.dev/wp-content/uploads/speaker/post-12275.mp3?cb=1679029672.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Human stem cell-based models to study synaptic dysfunction and cognition in schizophrenia: A narrative review – Stephanie Santarriaga et al. Schizophrenia Research.Full EntryHuman stem cell-based models to study synaptic dysfunction and cognition in schizophrenia: A narrative review –

https://psychiatry.dev/wp-content/uploads/speaker/post-12178.mp3?cb=1678347945.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Sleep-dependent memory consolidation in schizophrenia: A systematic review and meta-analysis – Review Cemal Demirlek et al. Schizophrenia Research. 2023. Sleep disturbances andFull EntrySleep-dependent memory consolidation in schizophrenia: A systematic review and meta-analysis –

https://psychiatry.dev/wp-content/uploads/speaker/post-12174.mp3?cb=1678344262.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Functional dysconnectivity of anterior cingulate subregions in schizophrenia and psychotic and nonpsychotic bipolar disorder – Sugai Liang et al. Schizophrenia Research. 2023.Full EntryFunctional dysconnectivity of anterior cingulate subregions in schizophrenia and psychotic and nonpsychotic bipolar disorder –

https://psychiatry.dev/wp-content/uploads/speaker/post-12148.mp3?cb=1678081928.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Catatonia in the peripartum: A cohort study using electronic health records – Afraa Delvi et al. Schizophrenia Research. 2023. Due to limitedFull EntryCatatonia in the peripartum: A cohort study using electronic health records –

https://psychiatry.dev/wp-content/uploads/speaker/post-12049.mp3?cb=1677478532.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Discontinuing cannabis use: Symptomatic and functional outcomes in people with an established psychotic disorder – A Waterreus et al. Schizophrenia Research. 2023.Full EntryDiscontinuing cannabis use: Symptomatic and functional outcomes in people with an established psychotic disorder –

https://psychiatry.dev/wp-content/uploads/speaker/post-11987.mp3?cb=1677220427.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Relational memory function in schizophrenia: Electrophysiological evidence for early perceptual and late associative abnormalities – Kara L Stevens et al. Schizophrenia Research.Full EntryRelational memory function in schizophrenia: Electrophysiological evidence for early perceptual and late associative abnormalities –

https://psychiatry.dev/wp-content/uploads/speaker/post-11958.mp3?cb=1677110297.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Personality traits in psychotic illness and their clinical correlates: A systematic review – Review Anne Neeltje Scholte-Stalenhoef et al. Schizophrenia Research. 2023.Full EntryPersonality traits in psychotic illness and their clinical correlates: A systematic review –

https://psychiatry.dev/wp-content/uploads/speaker/post-11927.mp3?cb=1677036364.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Abnormal brain network community structure related to psychological stress in schizophrenia – Mariana N Castro et al. Schizophrenia Research. 2023. Recent functionalFull EntryAbnormal brain network community structure related to psychological stress in schizophrenia –

https://psychiatry.dev/wp-content/uploads/speaker/post-11950.mp3?cb=1677102891.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Lorazepam in catatonia – Past, present and future of a clinical success story – Dusan Hirjak et al. Schizophrenia Research. 2023. TheFull EntryLorazepam in catatonia – Past, present and future of a clinical success story –

https://psychiatry.dev/wp-content/uploads/speaker/post-11943.mp3?cb=1677099230.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Association between visual impairment and psychosis: A longitudinal study and nested case-control study of adults – Natalie Shoham et al. Schizophrenia Research.Full EntryAssociation between visual impairment and psychosis: A longitudinal study and nested case-control study of adults –

https://psychiatry.dev/wp-content/uploads/speaker/post-11919.mp3?cb=1677028882.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Interactions between mood and paranoid symptoms affect suicidality in first-episode affective psychoses – Julie Ramain et al. Schizophrenia Research. 2023. Suicide preventionFull EntryInteractions between mood and paranoid symptoms affect suicidality in first-episode affective psychoses –

https://psychiatry.dev/wp-content/uploads/speaker/post-11400.mp3?cb=1673185242.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Systematic review of visual illusions in schizophrenia – Review Ana Luísa Lamounier Costa et al. Schizophrenia Research. 2023. Visual illusions have longFull EntrySystematic review of visual illusions in schizophrenia –

https://psychiatry.dev/wp-content/uploads/speaker/post-11360.mp3?cb=1672725875.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Means of suicide among adults with schizophrenia across the life span – Natalie Bareis et al. Schizophrenia Research. 2022. Adults with schizophreniaFull EntryMeans of suicide among adults with schizophrenia across the life span –

https://psychiatry.dev/wp-content/uploads/speaker/post-11352.mp3?cb=1672640452.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Weight changes in people with early psychosis treated with oral or long-acting injectable aripiprazole – Gordon Shymko et al. Schizophrenia Research. 2022.Full EntryWeight changes in people with early psychosis treated with oral or long-acting injectable aripiprazole –

https://psychiatry.dev/wp-content/uploads/speaker/post-11318.mp3?cb=1672294782.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Lower fractional anisotropy without evidence for neuro-inflammation in patients with early-phase schizophrenia spectrum disorders – Shiral S Gangadin et al. Schizophrenia Research.Full EntryLower fractional anisotropy without evidence for neuro-inflammation in patients with early-phase schizophrenia spectrum disorders –

https://psychiatry.dev/wp-content/uploads/speaker/post-11298.mp3?cb=1671876458.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Linguistic and non-linguistic markers of disorganization in psychotic illness – Einat Liebenthal et al. Schizophrenia Research. 2022. Disorganization, presenting as impairment inFull EntryLinguistic and non-linguistic markers of disorganization in psychotic illness –

https://psychiatry.dev/wp-content/uploads/speaker/post-11247.mp3?cb=1671430618.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Attributes of auditory hallucinations that are associated with self-harm: A prospective cohort study – Jordan DeVylder et al. Schizophrenia Research. 2022. ThereFull EntryAttributes of auditory hallucinations that are associated with self-harm: A prospective cohort study –

https://psychiatry.dev/wp-content/uploads/speaker/post-11235.mp3?cb=1671346136.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Altered expression of microglial markers of phagocytosis in schizophrenia – Aaron K Jenkins et al. Schizophrenia Research. 2022. Cognitive disturbances in schizophreniaFull EntryAltered expression of microglial markers of phagocytosis in schizophrenia –

https://psychiatry.dev/wp-content/uploads/speaker/post-11000.mp3?cb=1669703456.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Current progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview – Ashwani Choudhary et al. Schizophrenia Research. 2022.Full EntryCurrent progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview –

https://psychiatry.dev/wp-content/uploads/speaker/post-10952.mp3?cb=1669370699.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Pseudoneurotic symptoms in the schizophrenia spectrum: An empirical study – Andreas Rosén Rasmussen et al. Schizophrenia Research. 2022. Nonpsychotic symptoms (depression, anxiety,Full EntryPseudoneurotic symptoms in the schizophrenia spectrum: An empirical study –

https://psychiatry.dev/wp-content/uploads/speaker/post-10944.mp3?cb=1669363366.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Vocal acoustic features may be objective biomarkers of negative symptoms in schizophrenia: A cross-sectional study – Qing Zhao et al. Schizophrenia Research.Full EntryVocal acoustic features may be objective biomarkers of negative symptoms in schizophrenia: A cross-sectional study –

https://psychiatry.dev/wp-content/uploads/speaker/post-10936.mp3?cb=1669356060.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Computerized cognitive and social cognition training in schizophrenia for impulsive aggression – Anzalee Khan et al. Schizophrenia Research. 2022. Schizophrenia is associatedFull EntryComputerized cognitive and social cognition training in schizophrenia for impulsive aggression –

https://psychiatry.dev/wp-content/uploads/speaker/post-10924.mp3?cb=1669270616.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: The prognosis of schizophrenia: A systematic review and meta-analysis with meta-regression of 20-year follow-up studies – Ida-Marie Molstrom et al. Schizophrenia Research.Full EntryThe prognosis of schizophrenia: A systematic review and meta-analysis with meta-regression of 20-year follow-up studies –

https://psychiatry.dev/wp-content/uploads/speaker/post-10890.mp3?cb=1669103593.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Personality traits and coping strategies in recent-onset psychosis: Associations with symptom severity and psychosocial functioning – Matej Djordjevic et al. Schizophrenia Research.Full EntryPersonality traits and coping strategies in recent-onset psychosis: Associations with symptom severity and psychosocial functioning –

https://psychiatry.dev/wp-content/uploads/speaker/post-10862.mp3?cb=1669029996.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Latent structure of cognitive tests is invariant in men and women with schizophrenia – Megan L Becker Wright et al. Schizophrenia Research.Full EntryLatent structure of cognitive tests is invariant in men and women with schizophrenia –

https://psychiatry.dev/wp-content/uploads/speaker/post-10852.mp3?cb=1669015154.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Treatment of schizophrenia with catatonic symptoms: A narrative review – Stanley N Caroff et al. Schizophrenia Research. 2022. Catatonia is a neuropsychiatricFull EntryTreatment of schizophrenia with catatonic symptoms: A narrative review –

https://psychiatry.dev/wp-content/uploads/speaker/post-10848.mp3?cb=1669011445.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Brain mechanisms underlying catatonia: A systematic review – Giulia Cattarinussi et al. Schizophrenia Research. 2022. Catatonia is a complex psychomotor disorder characterizedFull EntryBrain mechanisms underlying catatonia: A systematic review –

https://psychiatry.dev/wp-content/uploads/speaker/post-10840.mp3?cb=1668874959.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Clinical phenotypes of five patients with psychotic disorders carrying rare schizophrenia-associated loss-of-function variants – Bruce M Cohen et al. Schizophrenia Research. 2022.Full EntryClinical phenotypes of five patients with psychotic disorders carrying rare schizophrenia-associated loss-of-function variants –

https://psychiatry.dev/wp-content/uploads/speaker/post-10832.mp3?cb=1668867573.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: The relationship between appraisals of auditory verbal hallucinations and real-time affect and social functioning – Benjamin Buck et al. Schizophrenia Research. 2022.Full EntryThe relationship between appraisals of auditory verbal hallucinations and real-time affect and social functioning –

https://psychiatry.dev/wp-content/uploads/speaker/post-10790.mp3?cb=1668406147.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Towards a temporospatial framework for measurements of disorganization in speech using semantic vectors – Terje B Holmlund et al. Schizophrenia Research. 2022.Full EntryTowards a temporospatial framework for measurements of disorganization in speech using semantic vectors –

https://psychiatry.dev/wp-content/uploads/speaker/post-10786.mp3?cb=1668321394.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Gut mycobiota dysbiosis in drug-naïve, first-episode schizophrenia – Xiuxia Yuan et al. Schizophrenia Research. 2022. Bacterial dysbiosis has been demonstrated in patientsFull EntryGut mycobiota dysbiosis in drug-naïve, first-episode schizophrenia –

https://psychiatry.dev/wp-content/uploads/speaker/post-10778.mp3?cb=1668251275.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Higher central set point of thyroid homeostasis in drug-naïve patients affected by first episode schizophrenia – Desheng Zhai et al. Schizophrenia Research.Full EntryHigher central set point of thyroid homeostasis in drug-naïve patients affected by first episode schizophrenia –

https://psychiatry.dev/wp-content/uploads/speaker/post-10768.mp3?cb=1668147414.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Parakinesia: A Delphi consensus report – Jack R Foucher et al. Schizophrenia Research. 2022. Abnormal movements are intrinsic to some forms ofFull EntryParakinesia: A Delphi consensus report –

Hugh T Alkemi, host of EntheoRadio, is honored for a second time with Psychedelic Research Renaissance Founding Father Rick Strassman, MD who has been on The Joe Rogan Experience just this month and on Entheoradio about two years ago. It's always a fun time discussing the impact of psychedelics from both a research and a cultural standpoint with Dr Rick. This show includes suggestions and speculations about consciousness and the ongoing hype filled, psychedelic trend in the United States and gets especially intense in the part two of this episode. This is part 1 of 2.Bio for Rick Strassman, MD:Rick Strassman was born in Los Angeles, California in 1952. He attended public schools in southern California's San Fernando Valley and graduated from Ulysses S. Grant High School in Van Nuys in 1969. As an undergraduate, he majored in zoology at Pomona College in Claremont California for two years before transferring to Stanford University, where he graduated with departmental honors in biological sciences in 1973. During summers in college, he worked for RedKen Laboratories, developing cosmetics and a line of hair dyes. In addition, he performed laboratory research at Stanford, on the development of the chicken embryo's nervous system. He attended the Albert Einstein College of Medicine of Yeshiva University in the Bronx, New York, where he obtained his medical degree with honors in 1977.Dr. Strassman took his internship and general psychiatry residency at the University of California, Davis, Medical Center in Sacramento, and received the Sandoz Award for outstanding graduating resident in 1981. After graduating, he worked for a year in Fairbanks, Alaska in community mental health and private psychiatric practice. From 1982-1983, he obtained fellowship training in clinical psychopharmacology research at the University of California, San Diego's Veteran's Administration Medical Center. He then served on the clinical faculty in the department of psychiatry at UC Davis Medical Center, before taking a full-time academic position in the department of psychiatry at the University of New Mexico School of Medicine in Albuquerque in 1984.At UNM, Dr. Strassman performed clinical research investigating the function of the pineal hormone melatonin in which his research group documented the first known role of melatonin in humans. He also began the first new US government approved clinical research with psychedelic drugs in over twenty years, focusing on DMT and to a lesser extent, psilocybin. He received grant support from the National Institutes of Health's National Institute on Drug Abuse, as well as from the Scottish Rite Foundation for Schizophrenia Research. Before leaving the University in 1995, he attained the rank of tenured Associate Professor of Psychiatry and was awarded the UNM General Clinical Research Center's Research Scientist Award.In 1984, he received lay ordination in a Western Buddhist order, and co-founded, and for several years administered, a lay Buddhist meditation group associated with the same order. Dr. Strassman underwent a four-year personal psychoanalysis in New Mexico between 1986 and 1990.From 1996 to 2000, while living in the Pacific Northwest of the United States, Dr. Strassman worked in community mental health centers in Washington State in Bellingham and Port Townsend. For the next four years, he had a solo private practice in Taos, New Mexico. After two years working near the Navajo Nation in Gallup NM, he returned to northern New Mexico in 2006, where he provided psychiatric services at a mental health center in Espanola. Since mid-2008, he has been writing full-time.Dr. Strassman's “DMT: The Spirit Molecule,” an account of his DMT and psilocybin studies, has sold a quarter-million copies as of mid-2021, and been translated into over a dozen languages, including Mandarin. He co-produced an independent documentary by the same name, which was the most-streamed independent drug documentary on Netflix. He also is the author of “DMT and the Soul of Prophecy,” “Joseph Levy Escapes Death,” and a co-author of “Inner Paths to Outer Space.”He has published over 40 peer-reviewed scientific papers and has served as a reviewer for 20 psychiatric research journals. He has been a consultant to the US Food and Drug Administration, National Institute on Drug Abuse, Veteran's Administration Hospitals, Social Security Administration, and other state and local agencies. He has provided consultation to many of the psychedelic startups that began appearing in 2020, including Atai, MindMed, and The Noetic Fund. He is on the Scientific Advisory Boards for Alexander Shulgin Research Institute and Ninnion Therapeutics.He currently is Clinical Associate Professor of Psychiatry at the University of New Mexico School of Medicine and lives in Gallup, New Mexico.ENTHEORADIO IS SPONSORED BY:Mushroom Shaman Brand Supplements and ServicesHttps://linktr.ee/mushroomshaman/Alkemi Ormus Products and ExtractsAlkemi.gold Buy his book through his site to get a personal inscription: https://www.rickstrassman.com/publications/the-psychedelic-handbook/The Psychedelic Handbook:Entering the world of psychedelic drugs can be challenging, and many aren't sure where to start. As research continues to expand and legalization looms on the horizon for psychedelics like psilocybin, you may need a guide to navigate what psychedelics are, how they work, and their potential benefits and risks.The Psychedelic Handbook is a complete manual that is accessible to anyone with an interest in these “mind-manifesting” substances. Packed with information on psilocybin, LSD, DMT/ayahuasca, mescaline/peyote, ketamine, MDMA, ibogaine, 5-methoxy-DMT (“the toad”), and Salvia divinorum/salvinorin A, this book is your ultimate reference for understanding the science and history of psychedelics; discovering their potential to treat depression, PTSD, substance abuse, and other disorders, as well as to increase wellness, creativity, and meditation; learning how to safely trip and explaining what we know about microdosing; and recognizing and caring for negative reactions to psychedelics.Clinical research psychiatrist, father of the American psychedelic research renaissance, and best-selling author of DMT: The Spirit Molecule, Dr. Rick Strassman shares his experience and perspectives as neither advocate nor foe of psychedelics in order to help readers understand the effects of these remarkable drugs.

Hugh T Alkemi, host of EntheoRadio, is honored for a second time with Psychedelic Research Renaissance Founding Father Rick Strassman, MD who has been on The Joe Rogan Experience just this month and on Entheoradio about two years ago. It's always a fun time discussing the impact of psychedelics from both a research and a cultural standpoint with Dr Rick. This part 2 of 2 of the interview becomes particularly intense and includes both powerful wisdom and cautionary speculation about the future of Psychedelics in the USA.Bio for Rick Strassman, MD:Rick Strassman was born in Los Angeles, California in 1952. He attended public schools in southern California's San Fernando Valley and graduated from Ulysses S. Grant High School in Van Nuys in 1969. As an undergraduate, he majored in zoology at Pomona College in Claremont California for two years before transferring to Stanford University, where he graduated with departmental honors in biological sciences in 1973. During summers in college, he worked for RedKen Laboratories, developing cosmetics and a line of hair dyes. In addition, he performed laboratory research at Stanford, on the development of the chicken embryo's nervous system. He attended the Albert Einstein College of Medicine of Yeshiva University in the Bronx, New York, where he obtained his medical degree with honors in 1977.Dr. Strassman took his internship and general psychiatry residency at the University of California, Davis, Medical Center in Sacramento, and received the Sandoz Award for outstanding graduating resident in 1981. After graduating, he worked for a year in Fairbanks, Alaska in community mental health and private psychiatric practice. From 1982-1983, he obtained fellowship training in clinical psychopharmacology research at the University of California, San Diego's Veteran's Administration Medical Center. He then served on the clinical faculty in the department of psychiatry at UC Davis Medical Center, before taking a full-time academic position in the department of psychiatry at the University of New Mexico School of Medicine in Albuquerque in 1984.At UNM, Dr. Strassman performed clinical research investigating the function of the pineal hormone melatonin in which his research group documented the first known role of melatonin in humans. He also began the first new US government approved clinical research with psychedelic drugs in over twenty years, focusing on DMT and to a lesser extent, psilocybin. He received grant support from the National Institutes of Health's National Institute on Drug Abuse, as well as from the Scottish Rite Foundation for Schizophrenia Research. Before leaving the University in 1995, he attained the rank of tenured Associate Professor of Psychiatry and was awarded the UNM General Clinical Research Center's Research Scientist Award.In 1984, he received lay ordination in a Western Buddhist order, and co-founded, and for several years administered, a lay Buddhist meditation group associated with the same order. Dr. Strassman underwent a four-year personal psychoanalysis in New Mexico between 1986 and 1990.From 1996 to 2000, while living in the Pacific Northwest of the United States, Dr. Strassman worked in community mental health centers in Washington State in Bellingham and Port Townsend. For the next four years, he had a solo private practice in Taos, New Mexico. After two years working near the Navajo Nation in Gallup NM, he returned to northern New Mexico in 2006, where he provided psychiatric services at a mental health center in Espanola. Since mid-2008, he has been writing full-time.Dr. Strassman's “DMT: The Spirit Molecule,” an account of his DMT and psilocybin studies, has sold a quarter-million copies as of mid-2021, and been translated into over a dozen languages, including Mandarin. He co-produced an independent documentary by the same name, which was the most-streamed independent drug documentary on Netflix. He also is the author of “DMT and the Soul of Prophecy,” “Joseph Levy Escapes Death,” and a co-author of “Inner Paths to Outer Space.”He has published over 40 peer-reviewed scientific papers and has served as a reviewer for 20 psychiatric research journals. He has been a consultant to the US Food and Drug Administration, National Institute on Drug Abuse, Veteran's Administration Hospitals, Social Security Administration, and other state and local agencies. He has provided consultation to many of the psychedelic startups that began appearing in 2020, including Atai, MindMed, and The Noetic Fund. He is on the Scientific Advisory Boards for Alexander Shulgin Research Institute and Ninnion Therapeutics.He currently is Clinical Associate Professor of Psychiatry at the University of New Mexico School of Medicine and lives in Gallup, New Mexico.ENTHEORADIO IS SPONSORED BY:Mushroom Shaman Brand Supplements and ServicesHttps://linktr.ee/mushroomshaman/Alkemi Ormus Products and ExtractsAlkemi.gold Buy his book through his site to get a personal inscription: https://www.rickstrassman.com/publications/the-psychedelic-handbook/The Psychedelic Handbook:Entering the world of psychedelic drugs can be challenging, and many aren't sure where to start. As research continues to expand and legalization looms on the horizon for psychedelics like psilocybin, you may need a guide to navigate what psychedelics are, how they work, and their potential benefits and risks.The Psychedelic Handbook is a complete manual that is accessible to anyone with an interest in these “mind-manifesting” substances. Packed with information on psilocybin, LSD, DMT/ayahuasca, mescaline/peyote, ketamine, MDMA, ibogaine, 5-methoxy-DMT (“the toad”), and Salvia divinorum/salvinorin A, this book is your ultimate reference for understanding the science and history of psychedelics; discovering their potential to treat depression, PTSD, substance abuse, and other disorders, as well as to increase wellness, creativity, and meditation; learning how to safely trip and explaining what we know about microdosing; and recognizing and caring for negative reactions to psychedelics.Clinical research psychiatrist, father of the American psychedelic research renaissance, and best-selling author of DMT: The Spirit Molecule, Dr. Rick Strassman shares his experience and perspectives as neither advocate nor foe of psychedelics in order to help readers understand the effects of these remarkable drugs.

Episode 62. Ever wondered what is beneath your pattern of emotional eating or binge eating? Often, it's dieting and restriction driving the cycle. However, underneath that, there many be something else going on too. If you've ever wondered what emotional eating or binge eating might be covering up, this conversation is for you? Dr. Sumer Ledet is a gem and a good friend of mine whose legs I've never seen. She is an incredible human being that I met online and now I consider her a very close support person in my life. I brought her on today because she has and incredible gift of breaking down complex topics like anxiety and guilt and living a values-consistent life. Today we cover all of this, including how it might be related to eating and your body image. I can't wait for you to listen in. We cover the following (and more!): Sumer's relationship with her body (something she hasn't shared much about in the past)What shifted things for her (Hint: It had nothing to do with therapy or treatment)What does it mean to clarify your values and why should you care about it? How might it help with feeling more in control of your eating? How you can use your values to motivate true change (and why if it's comfortable, you may be doing it wrong) "I believe we are all here for a purpose, and if you're not willing to check in with that, you might miss it" -Dr. Sumer Ledet Ready to Break the Emotional Eating Cycle? Ready to stop avoiding and break the emotional eating cycle for good? The first step is to start to disrupt the cycle. Grab my free guide for 23 practical ideas for things to do today besides the standard diet culture BS advice (take a walk, have some water!). Grab my free practical guide and start disrupting the cycle today today! Who is Dr. Sumer Ledet? Dr. Sumer Ledet is a licensed psychologist, anxiety expert, digital program creator, and working mother. Using her signature program, The Get Present System, she helps high achieving working mothers to finally enjoy the life they have worked so hard to create without being paralyzed by anxiety or having to fake being "OK" any longer. Since transitioning her business from a 1:1 brick-and-mortar private therapy practice to an online group coaching program during COVID, she is enjoying more time with my two boys and husband and practicing what she preaches more effectively than ever before. She has a doctorate and two master's degrees and is licensed as a Medical Psychologist. She has been published in the Psychology Times, the Louisiana Psychological Association blog, the journal of Schizophrenia Research, and has co-authored a book chapter on Schizophrenia. She has created hundreds of free educational videos to manage anxiety. You can check out a sample here: How I manage mom guilt Check her out on Facebook or Instagram @drsumerledetGet Present Bootcamp: www.sumerledet.com/bootcamp Main Takeaways From This Conversation Clarifying your values is everything. Do it! It's a foundational concept of both of our programs for a reason and consistently everyone's favorite Module in The Body Respect Program.Values are key for long-term motivation. To develop autonomous motivation, the type that sticks for the long-haul, doing this work is essential.If your comfortable, you may not be doing it right. Values clarification is inherently uncomfortable. We are never living 100% with our values and looking at the gaps (where you aren't living life exactly how you'd like to be) is sometimes really hard, but it's essential. And when you do it without judging or shaming yourself, it really isn't all that bad.Ask yourself "How do I want to show up in my life?" To dive in thoroughly, you can check out the book Get Out of Your Mind and Into Your Life by Dr. Steven Hayes, PhD. OR, you can ask questions like "How do I want to show up in my life?" Take the First Step to Break the Emotional Eating Cycle

Meet Rochelle Perry PMHNP (rdperry05241@gmail.com) to learn about how she's worked with her son on his use of Long-Acting Injectables (LAIs) and how she uses them in her outpatient settings. There is a lot of strong clinical evidence that this patient care pathway helps and it's very easy, with low barriers to us providing it right in our office. Learn more about that... listen and enjoy. References: Greene, M., Yan, T., Chang, E., Hartry, A., Touya, M., & Broder, M. S. (2018). Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder. Journal of Medical Economics, 21(2), 127–134. https://doi.org/10.1080/13696998.2017.1379412 (https://doi.org/10.1080/13696998.2017.1379412) Kishimoto, T., Hagi, K., Nitta, M., Leucht, S., Olfson, M., Kane, J. M., & Correll, C. U. (2018). Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies. Schizophrenia Bulletin, 44(3), 603–619. https://doi.org/10.1093/schbul/sbx090 (https://doi.org/10.1093/schbul/sbx090) Oliver, D., Davies, C., Crossland, G., Lim, S., Gifford, G., McGuire, P., & Fusar-Poli, P. (2018). Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies. Schizophrenia Bulletin, 44(6), 1362–1372. https://doi.org/10.1093/schbul/sbx166  Subotnik, K., Casaus, L., Ventura, J., Luo, J., Hellemann, G., Gretchen-Doorly, D., Marder, S., & Nuechterlein, K. (2015). Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia : A Randomized Clinical Trial. JAMA Psychiatry (Chicago, Ill.), 72(8), 822–829. https://doi.org/10.1001/jamapsychiatry.2015.0270 Titus-Lay, E. N., Ansara, E. D., Isaacs, A. N., & Ott, C. A. (2018). Evaluation of adherence and persistence with oral versus long-acting injectable antipsychotics in patients with early psychosis. The Mental Health Clinician, 8(2), 56–62. https://doi.org/10.9740/mhc.2018.03.056 (https://doi.org/10.9740/mhc.2018.03.056) Velligan, D. I., Maples, N. J., Pokorny, J. J., & Wright, C. (2020). Assessment of adherence to oral antipsychotic medications: What has changed over the past decade?. Schizophrenia Research, 215, 17–24. https://doi.org/10.1016/j.schres.2019.11.022 (https://doi.org/10.1016/j.schres.2019.11.022) Weiden, P. J., Claxton, A., Kunovac, J., Walling, D. P., Du, Y., Yao, B., Yagoda, S., Bidollari, I., Keane, E., & Cash, E. (2020). Efficacy and Safety of a 2-Month Formulation of Aripiprazole Lauroxil With 1-Day Initiation in Patients Hospitalized for Acute Schizophrenia Transitioned to Outpatient Care: Phase 3, Randomized, Double-Blind, Active-Control ALPINE Study. The Journal of Clinical Psychiatry, 81(3), 19m13207. https://doi.org/10.4088/JCP.19m13207 Contact PsychNP CastWant to be a guest? Fill this form out: https://forms.gle/tTQ8nChFaV4tKEj38 (https://forms.gle/tTQ8nChFaV4tKEj38) Email us Email: PsychNPcast@gmail.com

Schizophrenia Research and Wheat, Big Media Denial of the Facts and Fat from Wheat...